NDC 65649-400

Plenvu

Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Ascorbic Acid, Sodium

Plenvu is a Kit in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, In. The primary component is .

Product ID65649-400_46e1600f-4fd7-4189-9268-2bf48086c855
NDC65649-400
Product TypeHuman Prescription Drug
Proprietary NamePlenvu
Generic NamePolyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Ascorbic Acid, Sodium
Dosage FormKit
Marketing Start Date2018-05-04
Marketing CategoryNDA / NDA
Application NumberNDA209381
Labeler NameSalix Pharmaceuticals, In
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65649-400-01

1 KIT in 1 CARTON (65649-400-01) * 46.26 POWDER, FOR SOLUTION in 1 POUCH * 55.65 POWDER, FOR SOLUTION in 1 POUCH * 115.96 POWDER, FOR SOLUTION in 1 POUCH
Marketing Start Date2018-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65649-400-02 [65649040002]

Plenvu KIT
Marketing CategoryNDA
Application NumberNDA209381
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-05-04

NDC 65649-400-01 [65649040001]

Plenvu KIT
Marketing CategoryNDA
Application NumberNDA209381
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-05-04

Drug Details

OpenFDA Data

SPL SET ID:79f930fa-5674-4f30-8ae8-9448d6243797
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 2045244
  • 2045245
  • 2045233
  • 2045243
  • Medicade Reported Pricing

    65649040001 PLENVU POWDER PACKETS

    Pricing Unit: EA | Drug Type:

    Trademark Results [Plenvu]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PLENVU
    PLENVU
    79187028 5116648 Live/Registered
    Velinor AG
    2016-03-02

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.